首页> 美国政府科技报告 >Acute Intravenous Toxicity Study of Hypertonic Saline/Dextran 70 (Trade Name) and its Constituents in New Zealand White Rabbits
【24h】

Acute Intravenous Toxicity Study of Hypertonic Saline/Dextran 70 (Trade Name) and its Constituents in New Zealand White Rabbits

机译:新西兰白兔高渗盐水/右旋糖酐70(商品名)及其成分的急性静脉毒性研究

获取原文

摘要

The acute toxicity following intravenous administration of a proposed resuscitation fluid, hypertonic saline/ Dextran 70 (HSD), was evaluated in male and female New Zealand White rabbits. Animals received a single intravenous dose of HSD, 20 ml/kg over a 5-minute period, in an attempt to define maximum tolerated dosage. Equal volumes of each HSD component, 7.5% hypertonic saline (HS) and 6% Dextran 70 (D70) in normal saline, and Ringer's lactate (RL)/ were also evaluated. The animals in each group were divided into two subgroups according to necropsy, either Day 3 or Day 14 after dosing. Blood samples were collected for serum chemistry and hematologic analyses at necropsy on Day 3, and on Day 13. Observations were made at 1,2, and 4 hours after administration on the day of dosing and twice daily thereafter. HS produced death within 12 minutes of the start of injection in 6 of 20 rabbits. Compared to the control animals receiving RL, the HS and HSD groups exhibited increased incidence of bruising of the injected ear, inactivity, disorientation, and tremors. These data suggest that the lethality of HS was due to an acute hemodynamic effect of the volume administered, and that the rabbit was less sensitive to HSD or D70 than to HS. Since the proposed therapeutic dose of HSD is only 4 ml/kg, these findings indicate minimal adverse effects should be anticipated with the therapeutic administration of HSD. (aw)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号